Trials / Completed
CompletedNCT00462709
Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks
LEVP2006-4 CHANGE 3 Trial (C1-Inhibitor in Hereditary Angioedema Nanofiltration Generation Evaluating Efficacy): Open-Label Use of C1INH-nf (Human) for the Prophylactic Treatment to Prevent HAE Attacks and as Treatment in Acute HAE Attacks
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 146 (actual)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
The study objective was to evaluate the safety and efficacy of prophylactic use of C1INH-nf for the prevention of acute HAE attacks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | C1 esterase inhibitor [human] (C1INH-nf) |
Timeline
- Start date
- 2006-06-27
- Primary completion
- 2009-03-31
- Completion
- 2009-03-31
- First posted
- 2007-04-19
- Last updated
- 2021-06-08
- Results posted
- 2010-05-03
Locations
48 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00462709. Inclusion in this directory is not an endorsement.